Roche Introduces New PCR Test to Enhance Diagnostic Precision for Women with Vaginitis in CE Mark-Compliant Countries
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 09 2025
0mins
Source: Yahoo Finance
New PCR Test Introduction: Roche has launched the cobas® BV/CV assay, a PCR test that accurately identifies bacteria and yeast responsible for bacterial vaginosis and candida vaginitis using a single vaginal swab, improving diagnostic accuracy for millions of women affected annually.
Benefits of the Assay: The test enhances diagnostic efficiency by providing specific results faster than traditional methods, reducing the risk of incorrect treatments and allowing healthcare professionals to deliver targeted therapies more quickly.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.








